A randomized phase III, factorial design, of cabazitaxel and pelvic radiotherapy in patients with localized prostate cancer and high-risk features of relapse: The PEACE 2 trial from Unicancer

Blanchard, P.Foulon, S.Artignan, X.Carles, J.Ronchin, P.Gizzi, M.Villa Freixa, S.Valdagni, R.Sargos, P.Marques Da Costa, L. A.Duberge, T.Guillot, A.Latorzeff, I.Gallardo, E.Saez, M. I.Abadie-Lacourtoisie, S.Bennamoun, M.Hasbini, A.Tantot, F.Fizazi, K.2025-01-072025-01-072021-09-210923-7534https://hdl.handle.net/10668/27061enA randomized phase III, factorial design, of cabazitaxel and pelvic radiotherapy in patients with localized prostate cancer and high-risk features of relapse: The PEACE 2 trial from Unicancerconference outputopen access10.1016/j.annonc.2021.08.11591569-8041https://doi.org/10.1016/j.annonc.2021.08.1159700527701112